Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other financing activities: 2013-2024

Historic Other financing activities for Neurogene (NGNE) over the last 7 years, with Dec 2024 value amounting to $4.3 million.

  • Neurogene's Other financing activities was N/A to $166,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $4.3 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Neurogene's Other financing activities is $4.3 million, which was up 1,107.61% from $355,000 recorded in FY2020.
  • Neurogene's Other financing activities' 5-year high stood at $4.3 million during FY2024, with a 5-year trough of $355,000 in FY2020.
  • Moreover, its 1-year median value for Other financing activities was $4.3 million (2024), whereas its average is $4.3 million.
  • Data for Neurogene's Other financing activities shows a peak YoY increased of 0.85% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Neurogene's Other financing activities stood at $355,000 in 2020, then followed by $4.3 million in 2024.